These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 7605624

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. HMPAO SPET and FDG PET in Alzheimer's disease and vascular dementia: comparison of perfusion and metabolic pattern.
    Mielke R, Pietrzyk U, Jacobs A, Fink GR, Ichimiya A, Kessler J, Herholz K, Heiss WD.
    Eur J Nucl Med; 1994 Oct; 21(10):1052-60. PubMed ID: 7828614
    [Abstract] [Full Text] [Related]

  • 3. Positron emission tomography for diagnosis of Alzheimer's disease and vascular dementia.
    Mielke R, Heiss WD.
    J Neural Transm Suppl; 1998 Oct; 53():237-50. PubMed ID: 9700661
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Quantitative topographical EEG compared to FDG PET for classification of vascular and degenerative dementia.
    Szelies B, Mielke R, Herholz K, Heiss WD.
    Electroencephalogr Clin Neurophysiol; 1994 Aug; 91(2):131-9. PubMed ID: 7519142
    [Abstract] [Full Text] [Related]

  • 7. A comparison of FDG PET and IQNB SPECT in normal subjects and in patients with dementia.
    Weinberger DR, Jones D, Reba RC, Mann U, Coppola R, Gibson R, Gorey J, Braun A, Chase TN.
    J Neuropsychiatry Clin Neurosci; 1992 Aug; 4(3):239-48. PubMed ID: 1498576
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for dementia severity.
    Vander Borght T, Minoshima S, Giordani B, Foster NL, Frey KA, Berent S, Albin RL, Koeppe RA, Kuhl DE.
    J Nucl Med; 1997 May; 38(5):797-802. PubMed ID: 9170449
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. PET studies in dementia.
    Herholz K.
    Ann Nucl Med; 2003 Apr; 17(2):79-89. PubMed ID: 12790355
    [Abstract] [Full Text] [Related]

  • 15. Abnormalities of energy metabolism in Alzheimer's disease studied with PET.
    Heiss WD, Szelies B, Kessler J, Herholz K.
    Ann N Y Acad Sci; 1991 Apr; 640():65-71. PubMed ID: 1776760
    [Abstract] [Full Text] [Related]

  • 16. Clinical application of positron emission tomography for diagnosis of dementia.
    Ishii K.
    Ann Nucl Med; 2002 Dec; 16(8):515-25. PubMed ID: 12593416
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain 18 F-fluorodeoxyglucose positron emission tomography in neurodegenerative cognitive impairment and dementia: Delphi consensus.
    Nobili F, Arbizu J, Bouwman F, Drzezga A, Agosta F, Nestor P, Walker Z, Boccardi M, EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders.
    Eur J Neurol; 2018 Oct; 25(10):1201-1217. PubMed ID: 29932266
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Can PET data differentiate Alzheimer's disease from vascular dementia?
    Nagata K, Maruya H, Yuya H, Terashi H, Mito Y, Kato H, Sato M, Satoh Y, Watahiki Y, Hirata Y, Yokoyama E, Hatazawa J.
    Ann N Y Acad Sci; 2000 Apr; 903():252-61. PubMed ID: 10818514
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.